A Greener Tomorrow: White Biotechnology Market's Rise, Trends, and Projections to 2034
25 sept. 2023 05h58 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "The Global Market for White Biotechnology 2024-2034" report has been added to ResearchAndMarkets.com's offering. White biotechnology utilizes...
Dyadic to Present at BioProcess International
12 sept. 2023 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Cell and Gene Therapy CDMO Market, Focused on AAV, Set to Surge with 24.61% CAGR
30 août 2023 09h33 HE
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow,...
Global Biomanufacturing Viral Detection Market Set to Surpass $1.15 Billion by 2032, Fueled by Growing Biopharmaceutical Utilization
15 août 2023 07h28 HE
|
Research and Markets
Dublin, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The "Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User,...
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
09 août 2023 16h00 HE
|
Dyadic International, Inc.
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...
Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
26 juil. 2023 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023
20 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics" report has been added to ResearchAndMarkets.com's offering. The...
New National Directory Helps Biomanufacturers Accelerate Transition from Pilot to Commercial Scale
19 juil. 2023 07h15 HE
|
California Biomanufacturing Center
VACAVILLE, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- The California Biomanufacturing Center (CBC) today launched the BioProcess to Product (BioP2P) Network Directory, an online resource to help...
National Bioeconomy Network Launches Webinar Series
12 juil. 2023 10h23 HE
|
California Biomanufacturing Center
VACAVILLE, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Products (BIOP2P) Network announced it is launching the Spotlight Series, a collection of webinars featuring innovations and...
Liberation Labs Breaks Ground on its First Purpose-Built Precision Fermentation Biomanufacturing Facility
29 juin 2023 14h09 HE
|
Liberation Labs
RICHMOND, Ind., June 29, 2023 (GLOBE NEWSWIRE) -- Liberation Labs, today broke ground on its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility in Richmond,...